CNE000001L31
CNE000001L31
SL PHARM
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q1 '26 31.03.2026 |
|---|---|---|
Market & Enterprise Value | ||
Market Cap | 5.92B EUR | 7.8B EUR |
Enterprise Value | 4.69B EUR | 7.15B EUR |
Valuation Multiples | ||
Trailing P/E | -- | -- |
Forward P/E | -- | -- |
Price to Sales | 10.38x | 12.85x |
Price to Book | 1.2x | 1.53x |
EV/Revenue | 8.22x | 11.79x |
EV/EBITDA | 32.36x | 14.79x |
Price to FCF (P/FCF) | 14.77x | 126.25x |
EV/FCF | 11.7x | 115.82x |
FCF Yield | 6.77% | 0.79% |